CHAMPIONS ONCOLOGY, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3cb74e14-1858-4c0f-a264-b9084d077373/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.2k | 2025-05-01 – 2026-04-30 | evidence 0001628280-26-059373 |
| FY 2024 | $4.7k | 2024-05-01 – 2025-04-30 | evidence 0001628280-26-059373 |
| FY 2023 | $-7.3k | 2023-05-01 – 2024-04-30 | evidence 0001628280-26-059373 |
| FY 2022 | $-5.3M | 2022-05-01 – 2023-04-30 | evidence 0001628280-23-025464 |
| FY 2021 | $548.0k | 2021-05-01 – 2022-04-30 | evidence 0001628280-22-019309 |
| FY 2020 | $362.0k | 2020-05-01 – 2021-04-30 | evidence 0001628280-21-014464 |
| FY 2019 | $-2.1M | 2019-05-01 – 2020-04-30 | evidence 0001628280-21-014464 |
| FY 2018 | $128.0k | 2018-05-01 – 2019-04-30 | evidence 0001628280-19-009139 |
| FY 2017 | $-1.5M | 2017-05-01 – 2018-04-30 | evidence 0001628280-18-009773 |
| FY 2016 | $-6.9M | 2016-05-01 – 2017-04-30 | evidence 0001628280-18-009773 |
| FY 2015 | $-10.4M | 2015-05-01 – 2016-04-30 | evidence 0001628280-16-017936 |
| FY 2014 | $-13.1M | 2014-05-01 – 2015-04-30 | evidence 0001628280-16-017936 |
| FY 2013 | $-7.4M | 2013-05-01 – 2014-04-30 | evidence 0001144204-14-045199 |
| FY 2012 | $-6.3M | 2012-05-01 – 2013-04-30 | evidence 0001144204-13-041406 |
| FY 2011 | $-8.7M | 2011-05-01 – 2012-04-30 | evidence 0001144204-12-040031 |
| FY 2010 | $-3.8M | 2010-05-01 – 2011-04-30 | evidence 0001144204-12-040031 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHAMPIONS ONCOLOGY, INC. — all facts · Revenue · Operating Income